Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2026-01-04 @ 1:28 PM
Study NCT ID:
NCT01351103
Status:
COMPLETED
Last Update Posted:
2025-06-13
First Post:
2011-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Sponsor:
Novartis Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Pancreatic Cancer | View |
| None | BRAF Mutant Colorectal Cancer | View |
| None | Melanoma | View |
| None | Triple Negative Breast Cancer | View |
| None | Head and Neck Squamous Cell Cancer | View |
| None | Cervical Squamous Cell Cancer | View |
| None | Esophageal Squamous Cell Cancer | View |
| None | Lung Squamous Cell Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | LGK974 | View |
| None | pancreatic adenocarcinoma | View |
| None | BRAF mutant colorectal cancer | View |
| None | RNF43 mutation | View |
| None | RSPO fusion | View |
| None | melanoma | View |
| None | triple negative breast cancer | View |
| None | PDR001 | View |
| None | immunotherapy | View |
| None | head and neck scc | View |
| None | cervical scc | View |
| None | esophageal scc | View |
| None | lung scc | View |